Moleculin Biotech raises approximately $2.7 million from recent warrant exercises

Moleculin Biotech, Inc. announced it received approximately $2.7 million in gross proceeds from the exercise of warrants subsequent to its last quarterly filing.

Key Details

• Gross Proceeds: Approximately $2.7 million.
• Warrants Exercised: The proceeds are from the exercise of warrants to purchase 1,361,500 shares of common stock.
• Timing: The exercises occurred after the company's Form 10-Q filing on May 14, 2026.
• Updated Share Count: As of June 29, 2026, the company had 7,065,000 common shares outstanding.